QUESTCOR PHARMACEUTICALS INC's ticker is QCOR and the CUSIP is 74835Y101. A total of 251 filers reported holding QUESTCOR PHARMACEUTICALS INC in Q2 2013. The put-call ratio across all filers is 1.71 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2014 | $3,682,000 | -48.6% | 39,806 | -63.9% | 0.00% | -50.0% |
| Q1 2014 | $7,168,000 | +13.7% | 110,399 | -4.6% | 0.01% | 0.0% |
| Q4 2013 | $6,302,000 | -10.9% | 115,733 | -5.1% | 0.01% | -14.3% |
| Q3 2013 | $7,073,000 | +24.3% | 121,952 | -2.6% | 0.01% | +16.7% |
| Q2 2013 | $5,690,000 | – | 125,167 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BROADWOOD CAPITAL INC | 2,251,660 | $146,200,000 | 28.53% |
| Palo Alto Investors LP | 1,938,990 | $125,898,000 | 5.20% |
| Valiant Capital Management, L.P. | 599,100 | $38,900,000 | 4.77% |
| Espalier Global Management LLC | 1,284,800 | $83,422,000 | 4.66% |
| CAPITAL MANAGEMENT CORP /VA | 178,365 | $11,581,000 | 3.95% |
| Freestone Capital Holdings, LLC | 303,127 | $19,682,000 | 3.49% |
| RIVULET CAPITAL, LLC | 58,000 | $3,766,000 | 3.41% |
| Formidable Asset Management, LLC | 52,640 | $4,161,000 | 2.91% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,039,865 | $67,518,000 | 2.76% |
| GROESBECK INVESTMENT MANAGEMENT CORP /NJ/ | 89,561 | $5,815,000 | 2.62% |